Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / IRWD - Ironwood Pharmaceuticals reports Q2 earnings miss; reaffirms FY22 guidance


IRWD - Ironwood Pharmaceuticals reports Q2 earnings miss; reaffirms FY22 guidance

  • Ironwood Pharmaceuticals press release ( NASDAQ: IRWD ): Q2 Non-GAAP EPS of $0.21 misses by $0.09 .
  • Revenue of $97.23M (-6.5% Y/Y) misses by $6.28M .
  • Adjusted EBITDA was $56.0 million in the second quarter of 2022, compared to $65.2 million in the second quarter of 2021.
  • In 2022, Ironwood continues to expect : U.S. LINZESS Net Sales Growth Low single digits %; total revenue of $420 to $430 million vs. consensus of $429.93M and Adjusted EBITDA of >$250 million.

For further details see:

Ironwood Pharmaceuticals reports Q2 earnings miss; reaffirms FY22 guidance
Stock Information

Company Name: Ironwood Pharmaceuticals Inc.
Stock Symbol: IRWD
Market: NASDAQ
Website: ironwoodpharma.com

Menu

IRWD IRWD Quote IRWD Short IRWD News IRWD Articles IRWD Message Board
Get IRWD Alerts

News, Short Squeeze, Breakout and More Instantly...